Antonio Olry de Labry-Lima

13PUBLICATIONS
28CO-AUTHORS
Biosecurity science and invasive species ecologyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingCryptographyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 12, 2025
Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer.

María Del Pilar Briceño-Casado, Adrián Sánchez Vegas, Emilio Jesús Alegre-Del-Rey

|Aug 05, 2025
Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients.

Silvia Fenix-Caballero, Pablo Caleffa-Menendez, Carmen Maria Dominguez-Santana

|Apr 22, 2024
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system.

Silvia Fenix-Caballero, Adrián Sanchez-Vegas, Emilio Jesús Alegre Del-Rey

|Jun 10, 2023
Educational Strategies to Reduce Physician Shortages in Underserved Areas: A Systematic Review.

Alexandre Medeiros de Figueiredo, Antonio Olry de Labry Lima, Daniela Cristina Moreira Marculino de Figueiredo

Pageof 3